• Targeting ACE2 as a Therapy For
    COVID-19 PATIENTS
    LEARN MORE
  • Innovative Pharmocological Therapies

    FOR CARDIOVASCULAR DISEASES
  • Our Lead Project:
    APELIN ANALOG THERAPY
    LEARN MORE

To provide pharmacological therapies to patients with cardiovascular disease through innovative technologies.

We engage in the bench-to-bedside approach to medicine to accelerate in development of effective biotechnologies.

Keep up to date with our latest innovations, including Apelin Analog therapy.

Support us as we push the boundaries of medicine.

Company News

OUR LEAD PROJECT

Apelin Analogs

Activation of cardioprotective pathways to treat patients with heart failure, myocardial infarction, and pulmonary arterial hypertension.

LEARN MORE
ONGOING PROJECT

Angiotensin 1-7 Analogs

Cardiometabolic therapeutic agents to treat heart failure with preserved and reduced ejection fraction.

LEARN MORE
ONGOING PROJECT

ADAM17 Inhibitors

Inhibition of enzyme activity to prevent aortic aneurysm.

LEARN MORE